These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 33179144)

  • 1. Immunometabolic Pathways and Its Therapeutic Implication in Autoimmune Diseases.
    Wang T; Jiao Y; Zhang X
    Clin Rev Allergy Immunol; 2021 Feb; 60(1):55-67. PubMed ID: 33179144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunometabolism: an overview and therapeutic prospects in autoimmune diseases.
    Stathopoulou C; Nikoleri D; Bertsias G
    Immunotherapy; 2019 Jun; 11(9):813-829. PubMed ID: 31120393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunometabolism in systemic lupus erythematosus: Relevant pathogenetic mechanisms and potential clinical applications.
    Tzeng HT; Chyuan IT
    J Formos Med Assoc; 2021 Sep; 120(9):1667-1675. PubMed ID: 33836940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal energy metabolism in the pathogenesis of systemic lupus erythematosus.
    Cao S; Jiang J; Yin H; Wang L; Lu Q
    Int Immunopharmacol; 2024 Jun; 134():112149. PubMed ID: 38692019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTOR Regulation of Metabolism in Hematologic Malignancies.
    Mirabilii S; Ricciardi MR; Tafuri A
    Cells; 2020 Feb; 9(2):. PubMed ID: 32053876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mTOR signaling and metabolic regulation of T cells: new potential therapeutic targets in autoimmune diseases.
    Pierdominici M; Vacirca D; Delunardo F; Ortona E
    Curr Pharm Des; 2011 Dec; 17(35):3888-97. PubMed ID: 21933144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycolysis in Innate Immune Cells Contributes to Autoimmunity.
    Xu Y; Chen Y; Zhang X; Ma J; Liu Y; Cui L; Wang F
    Front Immunol; 2022; 13():920029. PubMed ID: 35844594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic regulation of type I interferon production.
    O'Carroll SM; Henkel FDR; O'Neill LAJ
    Immunol Rev; 2024 May; 323(1):276-287. PubMed ID: 38465724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism.
    Wan X; Liu Y; Zhao Y; Sun X; Fan D; Guo L
    PLoS One; 2017; 12(9):e0184213. PubMed ID: 28886081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunometabolism and systemic lupus erythematosus].
    Xiao YB; Guo MY; Zuo XX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1120-1124. PubMed ID: 30562794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism as a Target for Modulation in Autoimmune Diseases.
    Huang N; Perl A
    Trends Immunol; 2018 Jul; 39(7):562-576. PubMed ID: 29739666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic perspectives on the metabolism of lymphocytes in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Iwata S; Tanaka Y
    Expert Rev Clin Immunol; 2021 Oct; 17(10):1121-1130. PubMed ID: 34351835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review: Metabolic Control of Immune System Activation in Rheumatic Diseases.
    Perl A
    Arthritis Rheumatol; 2017 Dec; 69(12):2259-2270. PubMed ID: 28841779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging concepts of T cell metabolism as a target of immunotherapy.
    Chang CH; Pearce EL
    Nat Immunol; 2016 Apr; 17(4):364-8. PubMed ID: 27002844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis while Metformin Downregulates HIF-1α-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines.
    Tyszka-Czochara M; Bukowska-Strakova K; Kocemba-Pilarczyk KA; Majka M
    Nutrients; 2018 Jun; 10(7):. PubMed ID: 29958416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging.
    Perl A
    Ann N Y Acad Sci; 2015 Jun; 1346(1):33-44. PubMed ID: 25907074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Untapped Opportunity and Challenge of Immunometabolism: A New Paradigm for Drug Discovery.
    Mazumdar C; Driggers EM; Turka LA
    Cell Metab; 2020 Jan; 31(1):26-34. PubMed ID: 31839485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMPK and mTOR: sensors and regulators of immunometabolic changes during Salmonella infection in the chicken.
    Kogut MH; Genovese KJ; He H; Arsenault RJ
    Poult Sci; 2016 Feb; 95(2):345-53. PubMed ID: 26706353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunobiology of mTOR in autoimmunity.
    Suto T; Karonitsch T
    J Autoimmun; 2020 Jun; 110():102373. PubMed ID: 31831256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel hypoxia-inducible factor-1α inhibitor IDF-11774 regulates cancer metabolism, thereby suppressing tumor growth.
    Ban HS; Kim BK; Lee H; Kim HM; Harmalkar D; Nam M; Park SK; Lee K; Park JT; Kim I; Lee K; Hwang GS; Won M
    Cell Death Dis; 2017 Jun; 8(6):e2843. PubMed ID: 28569777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.